|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:Sinovac_Biotech_Inc.
|
|
gptkbp:clinicalTrials
|
gptkb:COVID-19_vaccine
Hepatitis A vaccine
Hepatitis B vaccine
COVID-19 vaccine distribution
Influenza vaccine
COVID-19 vaccine efficacy
COVID-19 vaccine safety
|
|
gptkbp:collaborations
|
academic institutions
research organizations
|
|
gptkbp:community
|
COVID-19 pandemic
disease prevention
immunization programs
global vaccination efforts
vaccine accessibility
|
|
gptkbp:focus
|
vaccine development
|
|
gptkbp:founded
|
2001
|
|
gptkbp:headquarters
|
gptkb:Beijing,_China
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sinovac Biotech
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:investmentFocus
|
vaccine production facilities
R&D for new vaccines
|
|
gptkbp:keyPeople
|
gptkb:Yin_Weidong
|
|
gptkbp:market
|
gptkb:Brazil
gptkb:Chile
gptkb:China
gptkb:Mexico
gptkb:Philippines
gptkb:Turkey
Indonesia
|
|
gptkbp:notableEvent
|
Hepatitis A vaccine
Hepatitis B vaccine
Influenza vaccine
|
|
gptkbp:partnerships
|
gptkb:GAVI_Alliance
WHO
|
|
gptkbp:products
|
gptkb:CoronaVac
|
|
gptkbp:regulatoryCompliance
|
gptkb:China_National_Medical_Products_Administration
gptkb:Indonesian_Food_and_Drug_Authority
gptkb:Philippine_Food_and_Drug_Administration
gptkb:Turkish_Medicines_and_Medical_Devices_Agency
gptkb:Brazilian_Health_Regulatory_Agency
gptkb:Mexican_Federal_Commission_for_Protection_against_Sanitary_Risk
|
|
gptkbp:research_focus
|
adjuvants
inactivated vaccines
viral vaccines
bacterial vaccines
|
|
gptkbp:subsidiary
|
gptkb:Sinovac_Biotech_Ltd.
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.sinovac.com
|